What Researchers Did
Researchers investigated the effectiveness of hyperbaric oxygen therapy as a salvage treatment for sudden sensorineural hearing loss in 15 patients whose initial steroid and vasodilator therapy failed, comparing them to a control group of 30 patients who received conventional treatment alone.
What They Found
The study group receiving hyperbaric oxygen therapy showed a higher rate of hearing improvement (46.6%, 7/15 cases) compared to the control group (13.3%, 4/30 cases). Their mean pure-tone hearing average threshold improved by 12.1 dB HL to 53.4 dB HL, significantly better than the control group's 2.7 dB HL gain, which resulted in a 67.9 dB HL threshold.
What This Means for Canadian Patients
If initial treatments for sudden hearing loss are unsuccessful, hyperbaric oxygen therapy might offer a beneficial alternative to improve hearing. This could provide a salvage option for patients experiencing persistent hearing loss after standard care.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A key limitation of this study is its small sample size and non-randomized design, which may limit the generalizability of the findings.